EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Stanford University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Ohio State University Comprehensive Cancer Center